Pharmaceutical Knowledge and Classification: The Development of Iressa and the Changing Diagnostic Practices of Lung Cancer
碩士 === 國立陽明大學 === 科技與社會研究所 === 106 === This thesis investigates the development and use of Iressa, the first targeted drug treating lung cancer. From Science, Technology and Society (STS) perspective, it argues that Irressa is the exceptional case in which East Asia played a significant role in it...
Main Authors: | Yeh-Han Wang, 王業翰 |
---|---|
Other Authors: | Wen-Hua Kuo |
Format: | Others |
Language: | zh-TW |
Published: |
2018
|
Online Access: | http://ndltd.ncl.edu.tw/handle/phy9mw |
Similar Items
-
The Anti-tumor Mechanism of Combine Destruxin B with Iressa in Human Lung Cancer Cells
by: Ying-Han Wang, et al.
Published: (2007) -
The Anti-tumor Mechanism of Combine Destruxin B with Iressa in Human Lung Cancer Cells
by: Ying-Han Wang, et al.
Published: (2007) -
Gefitinib (IRESSA) sensitive lung cancer cell lines show phosphorylation of Akt without ligand stimulation
by: Minegishi Yuji, et al.
Published: (2006-12-01) -
Dissecting DNA methylation characteristics in different chemosensitivity of Iressa-treated non-small cell lung cancers
by: Ping-Chun Yu, et al.
Published: (2005) -
GEFITINIB (IRESSA) IN THE TREATMENT OF BRAIN METASTASES FROM NON-SMALL CELL LUNG CARCINOMA
by: D. R. Naskhletashvili, et al.
Published: (2015-04-01)